Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hypertension

  Free Subscription


Articles published in Curr Opin Nephrol Hypertens

Retrieve available abstracts of 32 articles:
HTML format
Text format



Single Articles


    April 2017
  1. VAN BUREN PN
    Pathophysiology and implications of intradialytic hypertension.
    Curr Opin Nephrol Hypertens. 2017 Apr 8. doi: 10.1097/MNH.0000000000000334.
    PubMed     Text format     Abstract available


    December 2016
  2. CHEN C, Upadhyay A
    Renal denervation for uncontrolled hypertension: critical review of the evidence.
    Curr Opin Nephrol Hypertens. 2016.
    PubMed     Text format     Abstract available


    November 2016
  3. ADROGUE HJ, Madias NE
    Sodium and potassium in the pathogenesis of hypertension: focus on the brain.
    Curr Opin Nephrol Hypertens. 2016.
    PubMed     Text format     Abstract available


    October 2016
  4. SIDDIQUI M, Calhoun DA
    Refractory versus resistant hypertension.
    Curr Opin Nephrol Hypertens. 2016.
    PubMed     Text format     Abstract available


  5. PEVSNER-FISCHER M, Blacher E, Tatirovsky E, Ben-Dov IZ, et al
    The gut microbiome and hypertension.
    Curr Opin Nephrol Hypertens. 2016.
    PubMed     Text format     Abstract available


  6. ZIEGLER MG, Milic M
    Sympathetic nerves and hypertension in stress, sleep apnea, and caregiving.
    Curr Opin Nephrol Hypertens. 2016.
    PubMed     Text format     Abstract available


    September 2016
  7. WINKLEWSKI PJ, Radkowski M, Demkow U
    Neuroinflammatory mechanisms of hypertension: potential therapeutic implications.
    Curr Opin Nephrol Hypertens. 2016;25:410-416.
    PubMed     Text format     Abstract available


    May 2016
  8. FERENBACH DA, Bonventre JV
    Kidney tubules: intertubular, vascular, and glomerular cross-talk.
    Curr Opin Nephrol Hypertens. 2016;25:194-202.
    PubMed     Text format     Abstract available


    March 2016
  9. SALIH M, Fenton RA, Zietse R, Hoorn EJ, et al
    Urinary extracellular vesicles as markers to assess kidney sodium transport.
    Curr Opin Nephrol Hypertens. 2016;25:67-72.
    PubMed     Text format     Abstract available


    January 2016
  10. TIKKANEN I, Chilton R, Johansen OE
    Potential role of sodium glucose cotransporter 2 inhibitors in the treatment of hypertension.
    Curr Opin Nephrol Hypertens. 2016.
    PubMed     Text format     Abstract available


  11. VAN GOOR H, van den Born JC, Hillebrands JL, Joles JA, et al
    Hydrogen sulfide in hypertension.
    Curr Opin Nephrol Hypertens. 2016.
    PubMed     Text format     Abstract available


  12. NOVIKOV A, Vallon V
    Sodium glucose cotransporter 2 inhibition in the diabetic kidney: an update.
    Curr Opin Nephrol Hypertens. 2016;25:50-8.
    PubMed     Text format     Abstract available


    December 2015
  13. DALE BL, Madhur MS
    Linking inflammation and hypertension via LNK/SH2B3.
    Curr Opin Nephrol Hypertens. 2015.
    PubMed     Text format     Abstract available


  14. SALEH L, Danser JA, van den Meiracker AH
    Role of endothelin in preeclampsia and hypertension following antiangiogenesis treatment.
    Curr Opin Nephrol Hypertens. 2015.
    PubMed     Text format     Abstract available


  15. DIKALOV SI, Dikalova AE
    Contribution of mitochondrial oxidative stress to hypertension.
    Curr Opin Nephrol Hypertens. 2015.
    PubMed     Text format     Abstract available


    November 2015
  16. WEIR MR, Blantz RC
    Noteworthy observations in hypertension from 2015.
    Curr Opin Nephrol Hypertens. 2015.
    PubMed     Text format    


  17. WADE B, Abais-Battad JM, Mattson DL
    Role of immune cells in salt-sensitive hypertension and renal injury.
    Curr Opin Nephrol Hypertens. 2015.
    PubMed     Text format     Abstract available


  18. TOWNSEND RR, Reese PP, Lim MA
    Should living kidney donors with hypertension be considered for organ donation?
    Curr Opin Nephrol Hypertens. 2015;24:594-601.
    PubMed     Text format     Abstract available


    September 2015
  19. RUIZ-HURTADO G, Gorostidi M, Waeber B, Ruilope LM, et al
    Ambulatory and home blood pressure monitoring in people with chronic kidney disease. Time to abandon clinic blood pressure measurements?
    Curr Opin Nephrol Hypertens. 2015.
    PubMed     Text format     Abstract available


  20. GORAYA N, Wesson DE
    Dietary interventions to improve outcomes in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2015.
    PubMed     Text format     Abstract available


    July 2015
  21. MONTEZANO AC, Tsiropoulou S, Dulak-Lis M, Harvey A, et al
    Redox signaling, Nox5 and vascular remodeling in hypertension.
    Curr Opin Nephrol Hypertens. 2015.
    PubMed     Text format     Abstract available


  22. SPERATI CJ, Whaley-Connell A
    Novel therapeutics in hypertension and kidney disease.
    Curr Opin Nephrol Hypertens. 2015.
    PubMed     Text format    


    June 2015
  23. ABAIS-BATTAD JM, Rudemiller NP, Mattson DL
    Hypertension and immunity: mechanisms of T cell activation and pathways of hypertension.
    Curr Opin Nephrol Hypertens. 2015.
    PubMed     Text format     Abstract available


  24. JOSE PA, Raj D
    Gut microbiota in hypertension.
    Curr Opin Nephrol Hypertens. 2015.
    PubMed     Text format     Abstract available


    March 2015
  25. SIRCAR M, Thadhani R, Karumanchi SA
    Pathogenesis of preeclampsia.
    Curr Opin Nephrol Hypertens. 2015;24:131-8.
    PubMed     Text format     Abstract available


  26. TSURUYA K, Eriguchi M
    Cardiorenal syndrome in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2015;24:154-62.
    PubMed     Text format     Abstract available


  27. HOLWERDA KM, Karumanchi SA, Lely AT
    Hydrogen sulfide: role in vascular physiology and pathology.
    Curr Opin Nephrol Hypertens. 2015;24:170-6.
    PubMed     Text format     Abstract available


  28. MATSUKI K, Hathaway CK, Chang AS, Smithies O, et al
    Transforming growth factor beta1 and aldosterone.
    Curr Opin Nephrol Hypertens. 2015;24:139-44.
    PubMed     Text format     Abstract available


    January 2015
  29. FUKAMI K, Taguchi K, Yamagishi S, Okuda S, et al
    Receptor for advanced glycation endproducts and progressive kidney disease.
    Curr Opin Nephrol Hypertens. 2015;24:54-60.
    PubMed     Text format     Abstract available


  30. MITCHELL GF
    Arterial stiffness: insights from Framingham and Iceland.
    Curr Opin Nephrol Hypertens. 2015;24:1-7.
    PubMed     Text format     Abstract available


  31. HUANG C, Pollock CA, Chen XM
    KCa3.1: a new player in progressive kidney disease.
    Curr Opin Nephrol Hypertens. 2015;24:61-6.
    PubMed     Text format     Abstract available


    November 2014
  32. KNIGHT J, Wong MG, Perkovic V
    Optimal targets for blood pressure control in chronic kidney disease: the debate continues.
    Curr Opin Nephrol Hypertens. 2014;23:541-6.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: